The Waiting List That Won't Move: Augmentation's Safety Review, One Year On

For the estimated five percent of humanity now living with neural or somatic augmentation, the technology is settled fact. For the far larger number on the waiting side of it, this autumn is another season of not knowing. Somaform Augmetics' contested neural-interface safety review — open and unresolved through all of 2124 — has left a class of newer implants in a regulatory holding pattern, neither cleared nor withdrawn. "I was told 'soon' in the spring and 'soon' again last week," said Priya Deshmukh, 38, a warehouse coordinator in Pune who applied for a mobility augment and now waits behind a review she cannot influence. Clinicians defend the caution. "An implant is not a phone; you do not recall it from a pocket," said augmentation ethicist Dr. Rasheed Kone, who supports the review's patience even as he acknowledges its human cost. The debate over augmentation in daily life grows louder as the numbers grow. For those in the queue, the argument is measured in months of a life on hold.